Filing Details

Accession Number:
0001209191-17-017709
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-03 17:02:27
Reporting Period:
2017-03-01
Filing Date:
2017-03-03
Accepted Time:
2017-03-03 17:02:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1269021 Portola Pharmaceuticals Inc PTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192591 J Charles Homcy C/O Portola Pharmaceuticals, Inc.
270 East Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-01 25,000 $5.00 25,000 No 4 M Direct
Common Stock Disposition 2017-03-01 25,000 $37.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-03-01 25,000 $0.00 25,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
170,803 2007-09-20 2017-09-20 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2017.
  2. These shares were sold in a single transaction at a price of $37.50.